We are live on ! Find out more
NTC

North Tide Capital Portfolio holdings

AUM $469M
1-Year Est. Return 6.57%
This Fund
S&P 500
This Quarter Est. Return
-18.52%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.15B
AUM Growth
-$238M
Cap. Flow
+$27.4M
Cap. Flow %
2.39%
Top 10 Hldgs %
87.94%
Holding
23
New
1
Increased
5
Reduced
2
Closed
7

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$167M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$99.1M
3
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$23M
4
SVU
SUPERVALU Inc.
SVU
+$20.5M
5
SEM
Select Medical
SEM
+$1.38M

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$63M
2
GILD icon
Gilead Sciences
GILD
+$58.5M
3
STJ
St Jude Medical
STJ
+$36.5M
4
DGX icon
Quest Diagnostics
DGX
+$36.3M
5
MGLN
Magellan Health Services, Inc.
MGLN
+$35M

Sector Composition

Rank Sector Weight
1 Healthcare 78.83%
2 Technology 5.55%
3 Consumer Discretionary 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
1
Viatris
VTRS
$20.1B
$161M 14.04%
4,000,000
+3,000,000
+300% +$167M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$37.3B
$152M 13.29%
2,700,000
-300,000
-10% -$19.5M
AMED
3
DELISTED
Amedisys
AMED
$152M 13.24%
4,000,000
– –
SEM
4
DELISTED
Select Medical
SEM
$141M 12.32%
24,313,600
+185,600
+0.8% +$1.38M
SVU
5
DELISTED
SUPERVALU Inc.
SVU
$108M 9.39%
2,142,857
+357,143
+20% +$20.5M
KND
6
DELISTED
Kindred Healthcare
KND
$78.8M 6.87%
5,000,000
– –
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$63.9M 5.57%
+1,000,000
New +$99.1M
IMS
8
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$50.9M 4.44%
1,750,000
+750,000
+75% +$23M
OFIX icon
9
Orthofix Medical
OFIX
$468M
$50.6M 4.41%
1,500,000
– –
AFAM
10
DELISTED
Almost Family Inc
AFAM
$50.1M 4.36%
1,250,000
– –
TVTY
11
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$42.8M 3.73%
3,850,000
– –
ALGN icon
12
Align Technology
ALGN
$12.7B
$28.4M 2.47%
500,000
– –
ELOS
13
DELISTED
Syneron Medical Ltd
ELOS
$21.4M 1.87%
3,000,000
– –
VVUS
14
DELISTED
Vivus Inc
VVUS
$20.5M 1.79%
1,250,000
– –
NXGN
15
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$12.7M 1.11%
1,020,000
+20,000
+2% +$275K
AEGR
16
DELISTED
Aegerion Pharmaceuticals
AEGR
$12.5M 1.09%
919,414
-80,586
-8% -$1.43M
CYH icon
17
Community Health Systems
CYH
$465M
– –
-1,210,000
Closed -$63M
DGX icon
18
Quest Diagnostics
DGX
$23.3B
– –
-500,000
Closed -$36.3M
GILD icon
19
Gilead Sciences
GILD
$167B
– –
-500,000
Closed -$58.5M
LH icon
20
Labcorp
LH
$23.2B
– –
-291,000
Closed -$30.3M
OPCH icon
21
Option Care Health
OPCH
$3.41B
– –
-250,000
Closed -$3.63M
MGLN
22
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-500,000
Closed -$35M
STJ
23
DELISTED
St Jude Medical
STJ
– –
-500,000
Closed -$36.5M

Similar funds

SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return
DG
Davidson & Garrard Lynchburg, Virginia $425M AUM 14.62% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
JWM
Jacobus Wealth Management Milwaukee, Wisconsin $382M AUM 16.31% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
MCL
MIK Capital LLC New York $344M AUM 26.72% 1-Year Est. Return
GIIO
Gen IV Investment Opportunities New York $269M AUM 21.06% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

North Tide Capital's Q3 2015 Portfolio in Review

As of Q3 2015, North Tide Capital held 23 positions worth $1.15B, down 17% from $1.39B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

North Tide Capital's Q3 2015 filing shows 1 new, 5 increased, 2 reduced and 7 closed positions. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,000,000 shares worth $63.9M. The largest sale was Community Health Systems, an estimated $63M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 83% a quarter earlier, followed by Technology and Consumer Discretionary.

  • North Tide Capital's largest Q3 2015 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,000,000 shares worth $63.9M.
  • North Tide Capital added most to Viatris in Q3 2015, an estimated $167M increase.
  • North Tide Capital's biggest Q3 2015 reduction was Teva Pharmaceuticals, cutting an estimated $19.5M.
  • North Tide Capital fully exited Community Health Systems in Q3 2015, selling an estimated $63M.
  • North Tide Capital's ten largest holdings make up 88% of its $1.15B portfolio in Q3 2015.
  • North Tide Capital opened 1 new position and closed 7 in Q3 2015.
  • North Tide Capital's portfolio value fell 17% quarter-over-quarter to $1.15B.

Based on North Tide Capital's 13F filing for Q3 2015, filed 16 Nov 2015.